document submitted in a standardized template developed by the Secretary that includes such information described in subclauses (I) through (X). (ii) Standard formats Not later than June 1, 2025, the Secretary shall specify standard formats for pharmacy benefit managers to submit annual reports required under clause (i). (iii) Confidentiality (I) In general Information disclosed by a pharmacy benefit manager or PDP sponsor under this subsection that is not otherwise publicly available shall not be disclosed by the Secretary or a PDP sponsor receiving the information, except that the Secretary may disclose the information for the following purposes: (aa) As the Secretary determines to be necessary to carry out this part. (bb) To permit the Comptroller General to review the information provided. (cc) To permit the Director of the Congressional Budget Office to review the information provided. (dd) To permit the Executive Director of the Medicare Payment Advisory Commission to review the information provided. (ee) To the Attorney General for the purposes of conducting oversight and enforcement under this title. (II) Restriction on use of information The Secretary, the Comptroller General, the Director of the Congressional Budget Office, and the Executive Director of the Medicare Payment Advisory Commission shall not report on or disclose information disclosed pursuant to subclause (I) to the public in a manner that would identify a specific pharmacy benefit manager, affiliate, PDP sponsor, or plan, or prices charged for specific drugs. (C) Audit rights (i) In general Not less than once a year, at the request of the PDP sponsor, the pharmacy benefit manager shall allow for an audit of the pharmacy benefit manager to ensure compliance with all terms and conditions under the contract and the accuracy of information reported under subparagraph (B). (ii) Auditor The PDP sponsor shall have the right to select an auditor. The pharmacy benefit manager shall not impose any limitations on the selection of such auditor. (iii)